SMMT
#852
Summit Therapeutics Inc. - Common Stock
14.3 3 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.70%
Monthly Change
+13.64%
6 month change
-11.32%
Year Change
-27.84%
Previous Close
14.2 3
Open
14.3 3
Low
14.3 3
High
14.3 3
Volume
109
Financials
- Market Capitalization 11.43 B
- Employee 265
- Founded 2003
- CEO Robert DugganMaky Zanganeh
- Website www.smmttx.com
- Headquarter Florida, United States
- FIGI BBG00X3GQL76
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-12.15
Price to sales ratio
-21.44 K
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 809 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 88.59 USD | -0.59% | +0.50% | +3.54% | +126.57% | 12.51 B USD | ||
| 824 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 106.92 USD | -0.13% | +0.68% | +28.70% | +60.06% | 12.14 B USD | ||
| 857 |  TECH Bio-Techne Corp - Common Stock | 72.47 USD | +0.12% | +0.19% | +0.47% | +33.83% | 11.36 B USD | ||
| 875 |  CYTK Cytokinetics, Incorporated - Common Stock | 77.90 USD | -1.64% | +0.78% | -2.34% | +34.08% | 10.83 B USD |
Frequently asked questions about Summit Therapeutics Inc. Common Stock
What is the Summit Therapeutics Inc. Common Stock stock price today?
The current price of Summit Therapeutics Inc. Common Stock (SMMT) is 14.33. Over the past 24 hours, the stock has changed by +0.70%. Follow the SMMT chart for real-time price dynamics.
What is the stock ticker of Summit Therapeutics Inc. Common Stock?
Summit Therapeutics Inc. Common Stock trades under the ticker SMMT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Summit Therapeutics Inc. Common Stock stock going up?
SMMT has changed by +12.83% over the last week, +13.64% over the last month, and -27.84% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Summit Therapeutics Inc. Common Stock?
Summit Therapeutics Inc. Common Stock currently has a market capitalization of 11.43 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Summit Therapeutics Inc. Common Stock earnings last quarter?
Last quarter, Summit Therapeutics Inc. Common Stock reported earnings of -0.28 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Summit Therapeutics Inc. Common Stock revenue for the last quarter?
Summit Therapeutics Inc. Common Stock reported quarterly revenue of -90 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Summit Therapeutics Inc. Common Stock net income for the last quarter?
Summit Therapeutics Inc. Common Stock reported net income of -215.7 M for the last quarter. The previous quarter showed -189.42 M, which means net income changed by -13.87%.
How many employees does Summit Therapeutics Inc. Common Stock have?
As of the latest available data, Summit Therapeutics Inc. Common Stock has 265 employees. Workforce size can provide additional context about the company's scale and operations.
What is Summit Therapeutics Inc. Common Stock EBITDA?
Summit Therapeutics Inc. Common Stock EBITDA is -223.51 M, and its EBITDA margin is 248.34 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Summit Therapeutics Inc. Common Stock stock?
You can buy Summit Therapeutics Inc. Common Stock (SMMT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Summit Therapeutics Inc. Common Stock stock?
Investing in Summit Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SMMT chart and related analysis on metatrader.com as part of your research.